Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;45(3):366-377.
doi: 10.1007/s10865-022-00288-4. Epub 2022 Feb 2.

Symptom burden profiles in men with advanced prostate cancer undergoing androgen deprivation therapy

Affiliations

Symptom burden profiles in men with advanced prostate cancer undergoing androgen deprivation therapy

Blanca Noriega Esquives et al. J Behav Med. 2022 Jun.

Abstract

To identify symptom burden profiles among men with advanced prostate cancer undergoing androgen-deprivation therapy and examine their association with baseline sociodemographic and medical characteristics and psychosocial outcomes over time. Latent profile analysis was employed to identify distinct groups based on the Expanded Prostate Index Composite and the McGill Pain Questionnaire at baseline. Psychosocial outcomes were assessed at baseline, 6- and 12-month follow-ups. Three profiles emerged: "high symptom burden," "high sexual bother," and "low symptom burden." Men with "high symptom burden" were younger and exhibited higher baseline levels of depression, stress, cancer-specific distress, and anxiety than men in the other two groups. However, men with "high symptom burden" also demonstrated improvement in these psychosocial outcomes over time. Men with advanced prostate cancer who experience multiple co-occurring symptoms demonstrate worse psychosocial adjustment. Patients with substantial symptom burden, and specifically young men, may benefit from prompt referral to supportive care services.

Keywords: Androgen deprivation therapy; Latent profile analysis; Prostate cancer; Psychosocial well-being; Quality of life; Symptom burden.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest/Competing interests: The authors have no financial or non-financial interests to disclose.

Figures

Figure 1.
Figure 1.
Standardized conditional response means (z-scores) for symptom burden profiles

References

    1. Ader DN (2007). Developing the patient-reported outcomes measurement information system (PROMIS). In: LWW.
    1. Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, … Sanda MG (2011). Prediction of erectile function following treatment for prostate cancer. JAMA, 306(11), 1205–1214. doi:10.1001/jama.2011.1333 - DOI - PMC - PubMed
    1. Asparouhov T, & Muthén B (2020). Auxiliary Variables in Mixture Modeling: Using the BCH Method in Mplus to Estimate a Distal Outcome Model and an Arbitrary Secondary Model.
    1. Bakk Z, & Vermunt JK (2016). Robustness of Stepwise Latent Class Modeling With Continuous Distal Outcomes. Structural Equation Modeling: A Multidisciplinary Journal, 23(1), 20–31. doi:10.1080/10705511.2014.955104 - DOI
    1. Benedict C, Traeger L, Dahn JR, Antoni M, Zhou ES, Bustillo N, & Penedo FJ (2014). Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy. The journal of sexual medicine, 11(10), 2571–2580. - PMC - PubMed

Publication types

LinkOut - more resources